BOH
UTHR icon

Bank of Hawaii’s United Therapeutics UTHR Stock Holding History

Bank of Hawaii’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,003
Closed -$473K – 335
2016
Q3 		$473K Sell
4,003
-1,140
-22% -$137K 0.04% 231
2016
Q2 		$545K Sell
5,143
-1,725
-25% -$192K 0.06% 214
2016
Q1 		$765K Buy
6,868
+4,325
+170% +$547K 0.08% 184
2015
Q4 		$398K Buy
2,543
+855
+51% +$124K 0.05% 275
2015
Q3 		$222K Hold
1,688
– – 0.03% 341
2015
Q2 		$294K Sell
1,688
-2,675
-61% -$481K 0.03% 303
2015
Q1 		$752K Sell
4,363
-80
-2% -$12.2K 0.07% 200
2014
Q4 		$575K Sell
4,443
-4,140
-48% -$534K 0.05% 226
2014
Q3 		$1.1M Sell
8,583
-770
-8% -$79.4K 0.1% 160
2014
Q2 		$828K Buy
9,353
+7,138
+322% +$686K 0.08% 198
2014
Q1 		$208K Hold
2,215
– – 0.02% 325
2013
Q4 		$250K Buy
+2,215
New +$200K 0.03% 305
2013
Q3 		– Sell
-3,875
Closed -$255K – 335
2013
Q2 		$255K Buy
+3,875
New +$250K 0.03% 292

Other funds holding UTHR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of Hawaii's UTHR Position: Q4 2016 in Review

Bank of Hawaii sold out of United Therapeutics (UTHR) in Q4 2016, closing a stake of 4,003 shares — an estimated $473K sold.

Bank of Hawaii first reported a position in UTHR in Q2 2013 and held it in 13 quarters. The position peaked at $1.1M in Q3 2014. 406 funds tracked by Wall St. Rank hold UTHR as of Q4 2016.

  • Bank of Hawaii reported no remaining United Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Bank of Hawaii sold 4,003 United Therapeutics shares in Q4 2016, an estimated $473K.
  • Bank of Hawaii first reported a position in United Therapeutics in Q2 2013 and held it in 13 quarters.
  • Bank of Hawaii's United Therapeutics position peaked at $1.1M in Q3 2014.
  • 406 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2016.

Based on Bank of Hawaii's 13F filing for Q4 2016, filed 10 Feb 2017.